Amfenac

InformationAMG319 is a potent and selectivePI3Kδinhibitor withIC50of 18 nM, &gt:47-fold selectivity over other PI3Ks. Phase 2.TargetsPI3Kδ : PI3Kγ 18 nM: 850 nMIn vitroAMG319 inhibits anti-IgM/CD40L-induced B cell proliferation with IC50 of 8.6 nM

InformationAMG319 is a potent and selectivePI3Kδinhibitor withIC50of 18 nM, &gt:47-fold selectivity over other PI3Ks. Phase 2.TargetsPI3Kδ : PI3Kγ 18 nM: 850 nMIn vitroAMG319 inhibits anti-IgM/CD40L-induced B cell proliferation with IC50 of 8.6 nM

InformationAMG319 is a potent and selectivePI3Kδinhibitor withIC50of 18 nM, &gt:47-fold selectivity over other PI3Ks. Phase 2.TargetsPI3Kδ : PI3Kγ 18 nM: 850 nMIn vitroAMG319 inhibits anti-IgM/CD40L-induced B cell proliferation with IC50 of 8.6 nM

InformationAMG319 is a potent and selectivePI3Kδinhibitor withIC50of 18 nM, &gt:47-fold selectivity over other PI3Ks. Phase 2.TargetsPI3Kδ : PI3Kγ 18 nM: 850 nMIn vitroAMG319 inhibits anti-IgM/CD40L-induced B cell proliferation with IC50 of 8.6 nM

InformationAMG319 is a potent and selectivePI3Kδinhibitor withIC50of 18 nM, &gt:47-fold selectivity over other PI3Ks. Phase 2.TargetsPI3Kδ : PI3Kγ 18 nM: 850 nMIn vitroAMG319 inhibits anti-IgM/CD40L-induced B cell proliferation with IC50 of 8.6 nM

Bermoprofen (AD-1590) is an orally active non-steroidal anti-inflammatory agent. Bermoprofen has potent antipyretic activities with a short biological half-life. Bermoprofen is a potent antagonist of LPS-induced fever in rabbits .

Bermoprofen (AD-1590) is an orally active non-steroidal anti-inflammatory agent. Bermoprofen has potent antipyretic activities with a short biological half-life. Bermoprofen is a potent antagonist of LPS-induced fever in rabbits .

Bermoprofen (AD-1590) is an orally active non-steroidal anti-inflammatory agent. Bermoprofen has potent antipyretic activities with a short biological half-life. Bermoprofen is a potent antagonist of LPS-induced fever in rabbits .